ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 112 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,558,853 | +60.1% | 2,125,380 | +142.3% | 0.01% | +75.0% |
| Q2 2023 | $9,095,361 | +1013875.6% | 877,084 | +691.1% | 0.00% | – |
| Q1 2023 | $897 | -72.6% | 110,863 | -46.7% | 0.00% | -100.0% |
| Q4 2022 | $3,274 | -99.9% | 207,898 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $3,209,000 | +15.6% | 203,905 | +2.6% | 0.00% | 0.0% |
| Q2 2022 | $2,775,000 | +186.4% | 198,794 | +253.6% | 0.00% | +100.0% |
| Q1 2022 | $969,000 | -83.4% | 56,213 | -86.0% | 0.00% | -66.7% |
| Q4 2021 | $5,852,000 | -12.4% | 402,507 | +8.4% | 0.00% | -25.0% |
| Q3 2021 | $6,681,000 | +89.9% | 371,191 | +85.3% | 0.00% | +100.0% |
| Q2 2021 | $3,518,000 | -59.3% | 200,364 | -41.6% | 0.00% | -66.7% |
| Q1 2021 | $8,650,000 | +539.8% | 343,247 | +64.3% | 0.01% | +500.0% |
| Q4 2020 | $1,352,000 | +86.7% | 208,926 | -25.9% | 0.00% | 0.0% |
| Q3 2020 | $724,000 | +16.0% | 281,798 | -26.8% | 0.00% | 0.0% |
| Q2 2020 | $624,000 | +17.1% | 384,935 | +36.6% | 0.00% | 0.0% |
| Q4 2019 | $533,000 | +89.7% | 281,848 | +8.2% | 0.00% | – |
| Q3 2019 | $281,000 | +264.9% | 260,451 | +636.0% | 0.00% | – |
| Q2 2019 | $77,000 | -38.4% | 35,386 | +69.3% | 0.00% | – |
| Q1 2019 | $125,000 | -93.6% | 20,902 | -81.1% | 0.00% | -100.0% |
| Q1 2018 | $1,942,000 | +567.4% | 110,827 | +839.4% | 0.00% | – |
| Q4 2017 | $291,000 | -28.9% | 11,798 | -21.8% | 0.00% | -100.0% |
| Q2 2017 | $409,000 | +39.6% | 15,092 | +53.7% | 0.00% | 0.0% |
| Q1 2017 | $293,000 | – | 9,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |